To the Editor-in-Chief:
Atherosclerosis is the leading cause of death in the developed societies, probably related in part to relatively high-fat diets. The leading risk factor for the disease, however, is aging. A study of 19 different ethnic population groups demonstrated approximately linear rates of increases (although with different slopes) in the extent to which the intimal surfaces of aging aortas and coronary arteries develop raised, fibrotic, lipid-containing atheromas. 1 The great majority of deaths from atherosclerosis (typically via myocardial infarctions) occur after the age of 45. Quantitative studies 2–4 have demonstrated that genetic alleles responsible for phenotypes that are expressed beyond this age essentially fail to contribute to the gene pool of successive generations, thus escaping the force of natural selection. These alleles, however, may have been under strong selective pressure during earlier phases of the life course. This phenomenon has been referred to as “antagonistic pleiotropy” or “negative pleiotropy.” 5,6
I suggest that atherosclerosis may fall into this category of gene action and that its remarkably high prevalence in our species is a result of strong selective pressures for the retention of genes that enhance reproductive fitness early in the life course despite their deleterious effects on the vascular system postreproductively. It is likely that others have entertained or published such notions. One purpose of this correspondence is to ask my colleagues to inform me about the scientific history of this idea, which, it seems to me, is of seminal importance to the incipient discipline of evolutionary medicine. 7
The second purpose of this communication is to point out recent experimental support for this proposition 8 that was not discussed in the context of evolutionary biology. The study was motivated by a theory of atherogenesis that invokes a major role for arterial wall damage mediated by posttranslationally modified (particularly oxidized) low density lipoproteins. 9–11 These molecules are picked up by macrophages, the body’s scavengers, via particular classes of promiscuous receptors (“molecular flypaper”), 12 the macrophage scavenger receptors. These macrophages are thought to be the major sources of the lipid-laden foam cells that appear in the early “fatty streak” stage of atherogenesis.
Although rodents are notoriously resistant to spontaneous atherosclerosis, mice homozygous for null mutations at the apolipoprotein E locus develop marked hyperlipidemia and a form of progressive atherosclerosis; lipoprotein oxidation appears to play a role in the pathogenesis. 13 Suzuki et al 8 crossed such mice with mice bearing targeted lesions in a macrophage scavenger receptor gene. Such doubly deficient mice were found to be significantly more resistant to atherosclerosis. Also of great interest was the finding that mice deficient in macrophage scavenger receptor function were highly susceptible to infection by a gram-positive bacterium, Listeria monocytogenes, and by the type 1 human herpesvirus. The relevant macrophage receptor had previously been shown to bind to a wide range of gram-positive bacteria, including streptococci, staphylococci, and enterococci 14 as well as to a form of bacterial endotoxin. 15 There is less information concerning the potential role of macrophage scavenger receptors in the defense against viral agents, but a role for nonparenchymal liver cells in the clearance of plasmids 16 and the binding of certain classes of polynucleotides to macrophage scavenger receptors 17 is consistent with such a role.
The genomes of today’s populations of Homo sapiens have been substantially shaped by the selective resistance to infectious disease of remote ancestors. 18 Gene action at the macrophage scavenger receptor locus on chromosome 8 19 has undoubtedly played an important role in this respect. Domains of that gene have ancient evolutionary origins 20 and potential roles in the defenses of multicellular organisms against microbial pathogens and their toxins. Given our present diets and our relatively long life spans (which, of course, have also been molded by ancient selective forces), 2 we now appear to be paying a price for such reproductive phases of our life histories. This hypothesis predicts that mutations and polymorphisms at the macrophage scavenger locus on chromosome 8 will modulate individual susceptibility to atherogenesis.
References
- 1.Eggen DA, Solberg LA: Variation of atherosclerosis with age. Lab Invest 1968, 18:571-579 [PubMed] [Google Scholar]
- 2.Hamilton WD: The moulding of senescence by natural selection. J Theor Biol 1966, 12:12-45 [DOI] [PubMed] [Google Scholar]
- 3.Charlesworth B: Evolution in age-structured populations. 1994. Cambridge University Press, New York
- 4.Martin GM, Austad SN, Johnson TE: Genetic analysis of aging: role of oxidative damage and environmental stresses. Nat Genet 1966, 13:25-34 [DOI] [PubMed] [Google Scholar]
- 5.Williams GC: E vol 1957, 11:398-411 [Google Scholar]
- 6.Rose MR: Evolutionary biology of aging. 1991. Oxford University Press, New York
- 7.Williams GC, Nesse RM: The dawn of Darwinian medicine. Q Rev Biol 1991, 66:1-22 [DOI] [PubMed] [Google Scholar]
- 8.Suzuki H, Hurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Kodama T, et al: A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997, 386:292-296 [DOI] [PubMed] [Google Scholar]
- 9.Brown MS, Goldstein JC: Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983, 52:223-261 [DOI] [PubMed] [Google Scholar]
- 10.Aviram M: Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants. Eur J Clin Chem Clin Biochem 1996, 34:599-608 [PubMed] [Google Scholar]
- 11.Steinberg D: Lewis A: Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997, 95:1062–1071 [DOI] [PubMed]
- 12.Krieger M, Acton S, Ashkenas J, Pearson A, Penman M, Resnick D: Molecular flypaper, host defense, and atherosclerosis: structure, binding properties, and functions of macrophage scavenger receptors. J Biol Chem 1993, 268:4569-4572 [PubMed] [Google Scholar]
- 13.Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL: ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb 1994, 14:605-616 [DOI] [PubMed] [Google Scholar]
- 14.Dunne DW, Resnick D, Greenberg J, Krieger M, Joiner KA: The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. 1867. 1863– Proc Natl Acad Sci USA 1994 [DOI] [PMC free article] [PubMed]
- 15.Ashkenas J, Penman M, Vasile E, Acton S, Freeman M, Krieger M: Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors. J Lipid Res 1993, 34:983-1000 [PubMed] [Google Scholar]
- 16.Yoshida M, Mahoat RI, Kawabata K, Takakura Y, Hashida M: Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system. Pharmaceutical Res 1996, 13:599-603 [DOI] [PubMed] [Google Scholar]
- 17.Pearson AM, Rich A, Krieger M: Polynucleotide binding to macrophage scavenger receptors depends on the formation of base- quartet-stabilized four-stranded helices. J Biol Chem 1993, 268:3546-3554 [PubMed] [Google Scholar]
- 18.Ewald PW: Evolution of Infectious Disease. 1994. Oxford University Press, New York
- 19.Emi M, Asaoka H, Matsumoto A, Itakura H, Kurihara Y, Wada Y, Kanamori H, Yazaki Y, Takahashi E, Lepert M, et al: Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene. J Biol Chem 1993, 268:2120-2125 [PubMed] [Google Scholar]
- 20.Freeman M, Ashkenas J, Rees DJ, Kingsley DM, Copeland NG, Jenkins NA, Krieger M: An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc Natl Acad Sci USA 1990, 87:8810-8814 [DOI] [PMC free article] [PubMed] [Google Scholar]